Johnny-come-latelies in stem cell therapy

Barely twelve months ago, the University of California San Diego opened their $127,000,000 stem cell research center to a blitz of media hoopla. And yet, just a few miles down the road, ProgenCell had already spent more than a decade quietly bringing stem cells to patients who need them. What might explain such a contrast?
Significant medical discoveries utilizing embryonic stem cells were made during the Clinton presidency that frightened some ethicists and raised concerns about abortion and cloning. The next president, George W

. Bush, made a great deal of noise vetoing Congressional attempts to fund stem cell research based on his interpretation of where embryonic stem cells might come from. The result, at least as far as medical research in the United States has been concerned, has been a semantic confusion, within public opinion, of devastating proportions. Stem cell therapy really has nothing to do with abortion nor with human cloning – it has to do with helping a patient’s body heal itself – yet public opinion condemned those medical advances to purgatory for twelve years.
So now the United States is trying to play catch-up with the rest of the world. New research centers receive massive investment in order to validate the rest of the world’s work. What they’re hoping to do is to offer the same services we’ve been offering … only at U.S. prices plus a surcharge to offset their start-up costs.
There is no reason to wait for your local clinic to get up to speed. If you have a degenerative condition, it ought to be addressed immediately. Start your recovery today by contacting ProgenCell for a complimentary evaluation of your case.